Department of Radiation and Chemotherapy Oncology, The Affiliated Longyan First Hospital of Fujian Medical University, Longyan, Fujian, P.R. China.
Department of Critical Care Medicine, The Second Hospital of Longyan, Longyan, Fujian, P.R. China.
Oncol Rep. 2017 Dec;38(6):3376-3386. doi: 10.3892/or.2017.6041. Epub 2017 Oct 17.
Overcoming resistance to chemotherapy is an arduous challenge in the treatment of colorectal cancer (CRC), particularly since the underlying molecular mechanisms remain obscure. In the present study, we reported that miR‑874-3p was markedly downregulated in CRC tissues compared with that in adjacent normal colorectal epithelial tissues. Upregulation of miR-874-3p attenuated the chemoresistance of CRC cells to 5-fluorouracil (5-FU) in vitro and in vivo. Conversely, inhibition of miR-874-3p yielded an opposite effect. Furthermore, our results demonstrated that miR-874-3p directly inhibited the expression of transcriptional co-activators YAP and TAZ of the Hippo signaling pathway, resulting in the inactivation of the TEAD transcription. Thus, our findings clarify a novel mechanism by which miR-874-3p restores chemotherapeutic sensitivity of CRC to 5-FU, indicating that offering miR-874-3p mimics in combination with 5-FU may serve as a new therapeutic strategy to circumvent the chemoresistance in CRC.
克服化疗耐药性是结直肠癌(CRC)治疗中的一个艰巨挑战,特别是因为其潜在的分子机制仍不清楚。在本研究中,我们报道 miR-874-3p 在 CRC 组织中明显低于相邻正常结直肠上皮组织。miR-874-3p 的上调可减轻 CRC 细胞对 5-氟尿嘧啶(5-FU)的体外和体内化疗耐药性。相反,抑制 miR-874-3p 则产生相反的效果。此外,我们的结果表明,miR-874-3p 可直接抑制 Hippo 信号通路的转录共激活因子 YAP 和 TAZ 的表达,从而使 TEAD 转录失活。因此,我们的研究结果阐明了 miR-874-3p 恢复 CRC 对 5-FU 化疗敏感性的新机制,表明提供 miR-874-3p 模拟物与 5-FU 联合使用可能成为克服 CRC 化疗耐药性的新治疗策略。